Monsanto Co (MON)

MON (NYSE:Chemicals) EQUITY
$89.66
neg -1.99
-2.17%
Today's Range: 89.53 - 92.41 | MON Avg Daily Volume: 3,169,400
Last Update: 05/05/16 - 4:01 PM EDT
Volume: 2,538,126
YTD Performance: -6.97%
Open: $92.07
Previous Close: $91.65
52 Week Range: $81.22 - $123.82
Oustanding Shares: 436,844,990
Market Cap: 41,006,639,211
6-Month Chart
TheStreet Ratings Grade for MON
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 7
Moderate Buy 0 0 0 0
Hold 6 6 7 7
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 2.07 2.07 2.13 2.13
Latest Dividend: 0.54
Latest Dividend Yield: 2.30%
Dividend Ex-Date: 04/06/16
Price Earnings Ratio: 29.80
Price Earnings Comparisons:
MON Sector Avg. S&P 500
29.80 28.90 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-3.85% -20.94% -14.57%
GROWTH 12 Mo 3 Yr CAGR
Revenue -5.40 0.10 0.04
Net Income -15.80 0.10 0.03
EPS -7.90 0.30 0.08
Earnings for MON:
EBITDA 4.63B
Revenue 15.00B
Average Earnings Estimates
Qtr (05/16) Qtr (08/16) FY (08/16) FY (08/17)
Average Estimate $2.41 $-0.02 $4.68 $5.48
Number of Analysts 8 8 10 10
High Estimate $2.73 $0.15 $4.80 $6.05
Low Estimate $2.25 $-0.23 $4.60 $5.20
Prior Year $2.39 $-0.19 $5.73 $4.68
Growth Rate (Year over Year) 0.99% 87.50% -18.27% 17.02%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

My Takeaways and Observations Real Money Pro($)

The U.S. dollar continues to weaken. Crude oil fell by $1.05, trading at $44.87. Nat gas was a dime lower. Gold rose by another $5 and is approaching $1,300. The precious metal did trade over $1,300 earlier in the day. Agricultural commodities: wheat -4.50, soybean +8.00, corn -3.75 and oats flat. Lumber -2.60. Bonds got taken to the woodshed. iShares 20+ Year Treasury Bond ETF (TLT) was down about a beaner. The yield on the 10-year U.S. note added three basis points to 1.85% and the long bond climbed four basis points in yield to 2.70%. Municipals sold off, but closed-end municipal bond funds were mixed to higher. High yield sold off. However, Blackstone/GSO Strategic Credit Fund (BGB) traded up a nickel and is approaching $14. Banks prospered, led by JPMorgan Chase (JPM). Brokerages were strong -- Morgan Stanley (MS) up 20 cents and Goldman Sachs (GS) $2.50. Life insurance responded well to higher rates and lower bond prices, with smart gains in Lincoln  National (LNC), MetLife (MET) and HIG. Energy stocks were mixed. Schlumberger (SLB) was a standout loser, though Exxon Mobil (XOM) was up 50 cents. Old media was mixed. IBM (IBM), despite Warren's endorsement, was slightly lower, while Microsoft (MSFT) was up 50 cents. Retail stocks rebounded, with short Nordstrom (JWN) recovering a portion of Friday's big loss. Media thrived. Disney (DIS) was up $1.10 and Comcast (CMCSA) 55 cents. Consumer staples did well, led by former long Procter & Gamble (PG). Biotech, the object of affection to value players this year, continued to be pressured. iShares Nasdaq Biotechnology (IBB) was down a couple. VRX recovered two-thirds of its nearly $4 loss today. My biotech basket continues to roll over. Autos were up small -- General Motors (GM) and Ford (F) a dime higher, each. Ag equipment was flat. (T)FANG recovering well, led by Amazon (AMZN), which seemingly got an endorsement from Warren Buffett over the weekend and was up $23. By contrast, Tesla (TSLA) was down by $2, though it was lower. NOSH had all four components to the good, including Starbucks (SBUX), a short. CRABBY's six components also were all higher. In terms of miscellaneous stocks, Apple (AAPL) continues to be rotten to the core, down 50 cents. Twitter (TWTR) was awful and Potash (POT) was not much better, though rival Monsanto (MON) was up. Radian Group (RDN) and Oaktree Capital Group (OAK) were flat, as was DuPont (DD) after a big upside move. Warren's fav (but my short!) Coca-Cola (KO) was up 30 cents. iShares China Large-Cap ETF (FXI), last week's Trade of the Week, was off a dime after a very weak Friday. Here is some good stuff on Real Money Pro today: Jim "El Capitan" Cramer on the U.S. dollar.   Robert "Not Rita" Moreno on the dreaded Coppock Curve!  Bret "Meet George" Jensen on four possible biotech targets.  The Count's take on the Berkshire Hathaway meeting.  RevShark on ... what is the market theme and on the lack of clear market leadership (a theme others like Jimmy and myself are concerned about)? 
The interest areas of these investors span health care, hotels and international intrigue. Real Money takes a quick look at what they may discuss Wednesday.

My Takeaways and Observations Real Money Pro($)

Inside day in the markets, at least as of 3 p.m. ET (in the time that it took to write "Takeaways," the S&P rose by seven handles). Ss (S&P) over Ns (Nasdaq). The U.S. dollar weakened after the Fed's comments. Crude oil advanced by $1.13 to $45.17. Gold rose by $4.60 to $1,248. Agricultural commodities gave back on price. Wheat -3.25, corn -3.25, soybean -3.00 and oats +2.50. Lumber +9.20. Bonds erupted higher in price, lower in yield after above. That is why I re-shorted Financial Select Sector SPDR ETF (XLF) at $23.73. The yield on the 10-year U.S. note dropped by an outsize seven basis points to 1.86% and the long bond by five basis points to 2.70%. Municipals were well-bid and closed-end municipal bond funds advanced ... again. Big mistake selling them earlier in the year on my part! The high-yield bond market moved higher. Blackstone/GSO Strategic Credit Fund (BGB) paused and was flat. Banks experienced some early strength, sold off on the Fed's comments and are beginning to rally from the lows. Brokerages were stronger. Life insurance was unchanged despite the rise in bond prices. Retail was stronger across the board. Former long Macy's (M) was up 45 cents and short Nordstrom (JWN) was up 55 cents. Energy stocks rallied with crude oil. Schlumberger (SLB) rose $1.63 and Exxon Mobil (XOM) was up $1.00. Some positive dividend moves within the space. Old tech was quiet, though IBM (IBM) was up $1.60. Biotech was down most of the day, but experiencing a late day rally. iShares Nasdaq Biotechnology ETF (IBB) was down $1.70. My biotech basket of speculative stocks still appears to be rolling over. Consumer non-durables thrived, as Kimberly-Clark (KMB) bounced from recent weakness and Procter & Gamble (PG) was up 55 cents. Short Coca-Cola (KO) was fractionally higher. Autos were dead flat. Ag equipment was higher, with Caterpillar (CAT) up $1.15 and Deere (DE) up $1.50. (T)FANG continues weak, led by AMZN, down $9, and Tesla (TSLA), down $2.60. Trade of the Week short iShares China Large-Cap ETF (FXI) continues to rally, up 30 cents. NOSH was mixed; Starbucks (SBUX), a favorite short, continues to decline, down 72 cents. It appears to be breaking down from the earnings report last week. Mine is a minority view. CRABBY was helped by Radian Group (RDN), which had an earnings beat and some good credit data (more to come later in the week). In miscellaneous names, Twitter (TWTR) was a twit and Potash (POT) rallied by 40 cents after Monsanto (MON) was upgraded yesterday. Apple was down between $6 and $7 most of the day. Here are some good columns from RealMoneyPro today: Jim "El Capitan" Cramer on the market, which is impervious to Apple.  Apple mea culpa (I respect his candidness) from Mark Sebastian.  Shad Gad "And the Pharoahs" on how to beat the pros.  James Passeri on Mr. Ackman Goes to Washington.  Jack and Jim on Twitter. 
The indicators are flashing buy.
U.S. stocks appear to be on their way to ending a 2-session losing streak. 
It is the third time in five quarters that it misses earnings expectations.
Monsanto reported a 13% decline in quarterly revenue.
Monsanto (MON), Mosaic Co. (MOS), Potash Corp. (POT) and many other agriculturally oriented stocks are all lower today.
Bearish
Mar 14, 2016 | 7:54 AM EDT
MON was downgraded to Neutral, Citigroup said. $95 price target. Company lacks near-term catalysts. 
A cut to profit forecasts and a bleak performance by the market for agricultural staples helps pull the biotech giant to the bottom of the index.

Columnist Conversations

$550 million to buy market on close.
breadth is weak and fear is rising in front NFP. we will add protection. BOUGHT SPY MAY 206 PUT AT 2.97 BOUGHT...
Market has lost early but slight gains, and now sports small losses. Equities don't seem to have much directi...
Is to find Yale Liebowitz's photo (he was Pablo's best friend in first grade) in The Donald First Grade photo!...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.